A yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...